Murine leukemia viruses (MuLVs) are a diverse group of retroviruses originating in mice. The viruses can be grouped into several distinct host ranges defined by their ability to infect various cell lines or cultures in vitro. In vitro host ranges of MuLVs are thought to be conferred by their respective envelope proteins, which specifically interact with distinct cellular receptors (18, 19, 25) . In addition to selective replication in different in vitro cell lines, MuLVs frequently exhibit selective tropism for different tissues in vivo (7, 24, 27) . Thus, the replication-competent Friend erythroleukemia-inducing virus (F-MuLV) replicates more efficiently in the spleen compared to the thymus in infected mice, whereas the SL3-3. MuLV and some polytropic MuLVs originating from AKR mice replicate preferentially in the thymus and induce thymic neoplasms (7, 8, 24, 27) . Very little is known about the factors that influence the tissue-specific replication of MuLVs or the relevance of such specificity to the disease process.
Until recently little was known concerning the MuLV genetic elements which influence disease specificity; however recent studies utilizing in vitro-constructed recombinants between viruses which differ in their oncogenicity have defined the viral long terminal repeat (LTR) as an important determinant of disease specificity for several MuLVs (1, 2, (11) (12) (13) 21) . The ecotropic AKV MuLV exhibits low in vivo infectivity and is not oncogenic, whereas the SL3-3 MuLV, as noted above, is thymotropic and induces * Corresponding author.
thymomas. Substitution of the AKV LTR with the LTR of SL3-3 yielded an MuLV which readily induced thymomas, similar to SL3-3 (21) . Another striking example of the involvement of the LTR in disease specificity was demonstrated by using in vitro-constructed recombinant MuLVs between F-MuLV and Moloney MuLV (M-MuLV) (1, 2) . F-MuLV induces predominantly erythroleukemias in susceptible mice, whereas M-MuLV induces predominantly lymphocytic leukemias. In vitro-constructed recombinants containing the structural genes of F-MuLV and the LTR of M-MuLV induce lymphocytic leukemia rather than erythroleukemia. Conversely, recombinants containing the structural genes of M-MuLV and the LTR of F-MuLV induce erythroleukemia rather than lymphocytic leukemia.
Several of the studies cited above have postulated that a critical element determining the specificity of disease may be an enhanced replication of the MuLV in a particular target tissue as a result of transcriptional enhancement by the LTR (1, 12, 13, 21) . In this regard, a recent study reported that substitution of the AKV LTR with the LTR of the thymotropic SL3-3 MuLV or the splenotropic F-MuLV resulted in recombinant viruses which were thymotropic or splenotropic, respectively (27) . Although this result demonstrated that the LTRs of SL3-3 and F-MuLV contain elements which influence tissue-specific replication, it did not exclude the possibility that the structural gene sequences of SL3-3 or F-MuLV may also exert an influence on virus replication in specific tissues.
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In this report we have examined the replication of FMuLV and M-MuLV and of reciprocal LTR recombinants between the two viruses in the spleens and thymuses of infected mice. We have found that the relative levels of virus replication in the spleens and thymuses of infected mice did not strictly correlate with the type of disease induced (erythroleukemia versus lymphocytic leukemia) but were strikingly dependent upon the time after inoculation. At early times after infection (1 week) all of the viruses replicated to high levels in the spleens but not the thymuses of infected mice and thus appeared splenotropic. Early in the preleukemic stage (2 weeks after infection) a predominant influence on tissue-specific replication was exerted by the LTR: those MuLVs containing the M-MuLV LTR replicated to high levels in both the spleen and thymus, whereas those containing the F-MuLV LTR replicated to high levels only in the spleen. At later times (5 to 8 weeks after infection) the MuLV structural genes predominantly influenced tissuespecific replication: MuLVs containing the structural genes of M-MuLV replicated to high levels in both the spleen and thymus, whereas those containing the structural genes of F-MuLV replicated to high levels in the spleen but to low levels in thymus. Our results indicated that both the LTRs and structural gene sequences of F-MuLV and M-MuLV exerted an influence on the tissue-specific replication, that a high level of virus replication in a tissue was not sufficient for transformation, and that high levels of replication in the target tissue may be required only transiently during an early preleukemic stage of disease.
MATERIALS AND METHODS
Viruses and mice. The sources of molecularly cloned isolates of F-MuLV and M-MuLV were described previously (16 FM-I2-infected mice, which exhibited low thymus titers, whereas group T2 (dashed line) refers to a subset (4 of 15) of FM-42-infected mice that exhibited high thymus titers. When standard error bars overlap, the bar is shown only in the nonoverlapping direction. In those cases where standard error bars overlap in both directions, the mean and the standard error bars are offset to the left of the plot. For all MuLVs, ICs could initially be detected with spleens cells of some animals at 4 days and with thymus cells at 5 days after infection. Thus, we have extrapolated the geometric means of the titers to zero (1 focus per 106 cells) at 4 days for spleen cells and at 5 days for between the MuLVs exhibiting the highest (FM-12) and the lowest (M-MuLV) average titers. Similarly, among the thymus titers, only the highest (FM-12) and lowest (F-MuLV) average titers were significantly different (P < 0.05). The finding that all of the MuLVs were initially splenotropic when inoculated into newborn mice was unexpected, considering the different oncogenic activities of the ecotropic MuLVs examined. As was reported with NFS/N mice (1, 2), IRW mice inoculated with M-MuLV or the in vitroconstructed recombinant containing the M-MuLV LTR (FM-12), develop almost exclusively thymomas, whereas mice inoculated with F-MuLV or the recombinant containing the F-MuLV LTR (MF-3) develop almost exclusively erythroleukemias (Sitbon, personal communication) .
Replication of ecotropic MuLVs in spleens and thymuses of mice 2 weeks after infection. The results above indicated that extensive fluctuations in the tissue-specific replication of the ecotropic MuLVs must occur at later times after inoculation. We therefore examined virus production in the spleens and thymuses of mice 2 weeks after infection with each of the MuLVs. At this age we found a striking correlation between the pattern of MuLV replication in the spleens and thymuses and the presence of the F-MuLV or M-MuLV LTR, respectively. The average titers for spleen cells were slightly higher (ca. twofold) than spleen titers for mice 1 week after infection with all viruses (Fig. 1A) ; however this difference was found to be statistically significant only with FM-I2-infected mice (P < 0.005). The thymus titers of mice infected with MuLVs containing the F-MuLV LTR (F-MuLV and MF-3) were elevated compared with mice at 7 days (P < 0.001) but were still quite low compared with the spleen titers (Fig. 1) . In contrast, titers from thymus cells of mice infected with MuLVs containing the M-MuLV LTR (M-MuLV and FM-12) were remarkably elevated compared with the levels found with these MuLVs at 1 week and were much higher than the thymus titers observed at 2 weeks after inoculation with either F-MuLV or MF-3 (Fig. 1B) . Thus the M-MuLV LTR very likely facilitated a more rapid infection of the thymus between 1 and 2 weeks of age than did the F-MuLV LTR.
Replication of ecotropic MuLVs in spleens and thymuses of mice 5 to 8 weeks after inoculation. Ecotropic virus replication in the spleens and thymuses of F-MuLV-or M-MuLVinfected mice 5 to 8 weeks after inoculation was similar to the replication observed at 2 weeks postinoculation. Both viruses exhibited moderate (ca. twofold) increases in the spleen and thymus IC titers compared with 2-week-old mice (Fig. 1) . However, the levels of replication of the recombinant viruses (MF-3 and FM-12) at 5 to 8 weeks were quite different from the levels observed at earlier times after inoculation. Between 2 and 5 to 8 weeks after infection, MF-3-infected mice exhibited an increase in the average spleen titer of approximately the same magnitude as was observed with F-MuLV-and M-MuLV-infected mice (Fig.  1A) . However, the thymus titers of MF-3-infected mice, which were low at 2 weeks after infection, had increased dramatically by 5 to 8 weeks (Fig. 1B) . This was in contrast to F-MuLV, which maintained comparatively low thymus titers during the same interval of time. Since MF-3 and F-MuLV do not differ in their LTRs, the increase in thymus thymus cells. The number of mice assayed for each virus at 1, 2, and replication of MF-3 must have been mediated by elements contained within the M-MuLV structural gene sequences. The analyses of ecotropic MuLV replication in the spleens and thymuses of FM-I2-infected mice at 5 to 8 weeks after infection was more complex than analyses with mice infected with F-MuLV, M-MuLV, or the recombinant MF-3 MuLV. In contrast to other MuLVs, which displayed increases in their average spleen titers between 2 weeks and 5 to 8 weeks after infection, FM-I2-infected mice exhibited a moderate but significant reduction (ca. 50%, P < 0.001) in the average spleen titer during this interval of time (Fig. 1A) . The thymus titers of FM-I2-infected mice varied over a wide range (1 x 103 to 6 x 104 foci in 106 cells), and examination of the thymus titers from individual mice revealed a clear bimodal distribution (Table 1) . A group comprising nearly three-fourths of the mice (11 of 15) (group Ti, Table 1 , Fig.   1B ) exhibited average thymus titers which were not significantly different than the low thymus titers observed with F-MuLV-infected mice. The remaining four mice (group T2, Table 1 , Fig. 1B ) exhibited thymus titers which averaged much higher (ca. 14-fold) and were more similar to thymus titers observed with M-MuLV. Considering that all of the FM-I2-infected mice tested had relatively high thymus titers at 2 weeks after infection (data not shown), it is very likely that the low thymus titers observed with the majority of FM-12-infected mice at 5 to 8 weeks were the result of decreases in the thymus titers rather than a delayed onset of thymus infection in these mice.
The results of the determinations of the spleen and thymus titers of the MuLVs at 5 to 8 weeks after infection indicated that tissue-specific replication at this time correlated more closely with the structural genes of the MuLVs than with the LTRs. Viruses containing the structural genes of M-MuLV (M-MuLV and MF-3) replicated to high titers in both the spleen and thymus, whereas mice infected with viruses containing the structural genes of F-MuLV (F-MuLV-and most FM-I2-infected mice) exhibited high titers in the spleen but relatively low thymus titers.
Bimodal distribution of thymus IC titers in leukemic FM-12-infected mice. The finding that some of the preleukemic FM-I2-infected mice at 5 to 8 weeks after infection exhibited high ecotropic MuLV titers in the thymus suggested the possibility that those preleukemic mice may have corresponded to mice at a later stage of disease progression than mice with low thymus titers. To examine this possibility, assays of spleen and thymus cells were carried out on FM-12-infected mice which had progressed to the leukemic stage. The leukemic FM-I2-infected mice selected for these analyses exhibited grossly enlarged thymuses (0.1 to 1.2 g) or spleens (0.4 to 2.1 g) or both. All spleen and thymus tumors were found by histochemical examination to be of lymphoid origin (data not shown). As was the case with preleukemic mice, the ecotropic MuLV titers from thymus cells of leukemic mice exhibited a clear bimodal distribution; 7 of 10 mice exhibited low ecotropic MuLV titers in the thymus (group TLl, Table 1 ), whereas three mice exhibited much higher (ca. 20-fold) thymus titers (group TL2, Table 1 ).
The data with FM-I2-infected mice in the late preleukemic or leukemic stage of disease indicated that the level of virus replication in the target organ at these times did not closely correlate with disease progression. It is of interest that the severely depressed levels of ecotropic MuLV replication observed with thymus cells of most FM-12-infected mice (groups Ti and TLl) were not apparent in the ecotropic MuLV titers observed with spleen cells from the same animals (Table 1 ). This result was surprising, considering that spleen tumors of lymphoid origin were observed in all but one of the leukemic mice. This finding suggested that lymphoid cells from splenic tumors of FM-12-infected mice were phenotypically distinct from cells of the thymic tumors. Thus, the splenic tumors may have resulted from transfor- (Fig. 2) . Treatment of the data in this manner revealed a number of features not readily apparent from the averaged values.
At 2 weeks and at 5 to 8 weeks the spleen/thymus titer ratios of F-MuLV-infected mice were essentially the same and were clearly discernible from the ratios of M-MuLVinfected mice at these times (Fig. 2) . No overlapping ratios were observed between F-MuLV and M-MuLV-infected mice, indicating that the distinction in tissue-specific replication between the two MuLVs was characteristic of all mice examined. Similarly, at 2 weeks after infection the ratios of MF-3-and FM-12-infected mice were distinct from each other, and their ranges approximately coincided with those of F-MuLV-or M-MuLV-infected mice, respectively. Thus, at 2 weeks a complete correspondence of tissuespecific replication with the presence of the F-MuLV or M-MuLV LTR was observed.
At 5 to 8 weeks after inoculation, the ratios of MF-3 mice shifted to a lower range which overlapped, but was not completely coincident with, ratios observed with M-MuLVinfected mice (Fig. 2) . The reduction in the spleen/thymus titer ratios, compared with those of mice 2 weeks after infection, was characteristic of all MF-3-infected mice tested at 5 to 8 weeks. The thymus titers of several MF-3-infected mice at 5 to 8 weeks were lower than most thymus titers of M-MuLV-infected mice. This was reflected in intermediate ratios for several MF-3-infected mice and also in a lower average thymus titer (ca. fourfold) for MF-3-infected mice compared with M-MuLV-infected mice at 5 to 8 weeks (Fig.  1) .
The ratios observed with FM-12-infected mice at 5 to 8
weeks after inoculation exhibited a broad range which overlapped with ratios observed with both F-MuLV-and M-MuLV-infected mice (Fig. 2) . Mice that had low thymus titers (group Ti, Fig. 2 ). Almost all of the ratios observed with the remaining FM-I2-infected mice had shifted to a higher range which overlapped, but was not completely coincident with, ratios observed with F-MuLVinfected mice. This shift reflected the low thymus titers of these mice compared with the titers observed at 2 weeks after infection (Fig. 1) . Some FM-12-infected mice had spleen titers which were lower than those of most F-MuLVinfected mice. This resulted in intermediate ratios for those mice and in a moderately decreased (ca. fourfold) average spleen titer compared with F-MuLV-infected mice at 5 to 8 weeks after inoculation (Fig. 1) . One exceptional mouse exhibited low titers in both the spleen and thymus, which resulted in a low spleen/thymus titer ratio. The analyses of the ratios with leukemic mice infected with FM-12 closely paralleled the analyses of FM-I2-infected mice at 5 to 8 weeks (Fig. 2) . From these analyses, it was apparent that the patterns of ecotropic MuLV replication in the spleens and thymuses of MF-3-and FM-12-infected mice at 2 weeks after infection were characteristic of the parental MuLV LTR donor. However by 5 to 8 weeks after infection the patterns of replication in MF-3-infected mice and most FM-12-infected mice had shifted to patterns more similar to the parental MuLV from which the structural genes were derived.
Polytropic MuLV replication in late-preleukemic mice. Inoculation of F-MuLV or M-MuLV in mice results in the generation of host range variants, termed polytropic or mink cell focus-inducing viruses, which are recombinants between the inoculated ecotropic MuLV and endogenous retroviral gene sequences of the mouse (16) (17) (18) (19) 26) . Such recombinant viruses have been suggested to be involved in the induction of leukemia by F-MuLV or M-MuLV (6, 28, 33, 36, 37) . It was of interest to examine the level of polytropic MuLV production in infected mice to determine whether a correla-tion was evident between ecotropic and polytropic MuLV replication. This was of particular interest in the case of FM-12-inoculated mice, which exhibited a marked decrease of ecotropic MuLV replication in the thymuses of most late-preleukemic mice as well as in the thymuses of mice with advanced lymphocytic leukemia (Fig. 1, Table 1 ). Conversely, MF3-infected mice exhibited an increase in ecotropic MuLV titers in thymuses of late-preleukemic mice but do not develop lymphocytic leukemia (Fig. 1) . It is possible that the level of polytropic MuLV replication, rather than the replication of the ecotropic MuLVs, correlates with the presence or absence of lymphocytic leukemia in FM-I2-or MF-3-infected mice, respectively.
The determinations of polytropic MuLV titers in latepreleukemic mice infected with FM-I2 revealed a close correspondance of ecotropic and polytropic MuLV replication ( Table 2 ). Mice that exhibited low ecotropic MuLV titers in the thymus (group Ti, Table 2 ) also exhibited low polytropic MuLV thymus titers, whereas mice that had high ecotropic MuLV titers in the thymus (group T2, Table 2 ) had correspondingly high polytropic MuLV titers. Likewise, the polytropic MuLV titers in spleens of FM-12-infected mice correlated with the ecotropic MuLV titers. This bimodal distribution of polytropic MuLV replication, in parallel with ecotropic MuLV replication, was also very clear for the leukemic mice infected with FM-I2 (data not shown).
Mice infected with F-MuLV, M-MuLV, or MF-3 exhibited correlations between polytropic and ecotropic MuLV replication similar to that observed with FM-I2-infected mice (Table 2) . High polytropic MuLV titers in the spleens and low polytropic titers in the thymuses of F-MuLVinfected mice paralleled the corresponding ecotropic MuLV titers. Similarly, the polytropic MuLV titers in both the spleens and thymuses of M-MuLV-and MF-3-infected mice corresponded approximately to the ecotropic MuLV titers. The ecotropic and polytropic MuLV titers in the thymuses of MF-3-infected mice were approximately 10-fold higher than the corresponding titers in F-MuLV-infected mice, but lower than the ecotropic and polytropic MuLV titers observed in the thymuses of mice infected with M-MuLV. The lower thymus titers in MF-3-infected mice, compared with MMuLV-infected mice, reflected the delayed infection of the thymus by MF-3. We have not yet determined whether the ecotropic or polytropic MuLV titers in the thymuses of older MF-3-infected mice reach the high levels observed in the thymuses of mice infected with M-MuLV.
The results of these experiments, in particular those with FM-I2 and MF-3, suggested that a high level of polytropic or ecotropic MuLV replication in older preleukemic mice was not sufficient or necessary for disease progression.
DISCUSSION
The results of this study demonstrated striking fluctuations in virus replication in the spleens and thymuses of infected mice at different times after inoculation. Our initial observation, that the spleen was the major target for replication at the earliest times after inoculation, was unexpected. This result suggested that the viruses did not initially exhibit different tropisms, and that the tissue-specific replication observed at later times may have been the result of events that occurred after the initial infection. These studies did not address the possibility that the viruses may infect different subsets of spleen cells; however in other ongoing studies electron microscopic examination of peripheral blood cells identified erythroid cells with budding C-type particles from mice 2 to 3 weeks after inoculation with each of these MuLVs (Sitbon, personal communication) . Therefore, any difference in the major types of spleen cells infected by the MuLVs is likely to be quantitative rather than qualitative.
A second striking observation of this study was the elevation of thymus titers observed at 2 weeks after infection with M-MuLV and FM-12 compared with F-MuLV and MF-3. A clear correlation of tissue-specific virus replication with the identity of the LTR was apparent only during this early preleukemic phase of the disease. The rapid infection of the thymus, which correlated with the presence of the M-MuLV LTR, occurred well after virus infection was established in the mouse, as evidenced by substantial spleen titers observed 1 week earlier (Fig. 1A) . There are several possible mechanisms that may explain the rapid infection of thymus cells by M-MuLV and FM-12 after a delay of 1 to 2 weeks. Among these are the secondary infection of the thymus by migration of infected cells from the spleen (or elsewhere), the generation of thymotropic recombinant viruses that facilitate infection of the thymus by pseudotyping the ecotropic virus, and the direct alteration of the ecotropic virus to yield a thymotropic variant. Each of these mechanisms would require a process secondary to the initial infection which could account for the delayed infection of the thymus. The possibility of direct genetic alteration of M-MuLV to yield a new ecotropic which was thymotropic appears unlikely, in that M-MuLVs reisolated from the thymuses of infected mice also appeared splenotropic at 1 week after infection (unpublished observations). An alternative explanation for the abrupt rise in thymus titers in M-MuLV-and FM-12-infected mice is that the lag in virus replication by the thymus is largely a kinetic phenomenon associated with a change in the mode of thymus infection after inoculation. Thymus cells may be much more refractory to infection by cell-free virus than spleen cells and may require a high multiplicity of virus for efficient infection. Initially, a small number of thymus cells may be infected by all of the viruses; however only those MuLVs containing the M-MuLV LTR (M-MuLV and FM-12) may produce sufficiently high levels of virus to readily infect neighboring cells. Virus spread by cell-to-cell contact would result in a geometric increase of infected thymus cells, which in turn could result in an abrupt rise of the IC titer between 1 and 2 weeks after infection. The relevance of the high level of replication of M-MuLV and FM-12 in the thymus at 2 weeks after infection to the induction of disease is not known. However, the finding that the level of replication of FM-12 did not correspond to the disease state of leukemic mice suggested that a high level of replication may be required only transiently during the early preleukemic stage of disease. It is possible that the rate of infection of the target tissue is more relevant to disease induction than the level of virus replication per se. Several recent studies suggest that leukemogenesis by M-MuLV is mediated by integration of the provirus near cellular onc genes, resulting in the transcriptional activation of the cellular gene by the M-MuLV LTR (9, 20, 29, 32, 34, 35 (Fig. 1) , and the pattern of replication in the spleens and thymuses of MF-3-infected mice at 5 to 8 weeks resembled the pattern observed with M-MuLVinfected mice (Fig. 2) . This was in contrast to F-MuLV, which did not establish high levels of thymus infection (Fig.  1) . Since Previous studies addressing tissue-specific replication of viruses have examined mice several weeks after irifection (7, 14, 27) , and it has been concluded that sequences within the the viral LTR exert a predominant influence on tissuespecific MuLV replication (14, 27) . Our studies also demonstrated a predominant influence of the LTR on tissue-specific replication, but only during a very early preleukemic stage of disease. Examination of replication at different times after infection indicated that important determinants of tissuespecific replication are contained within the structural gene elements of F-MuLV and M-MuLV as well as in the LTRs. It is apparent from the present studies that many factors may influence the tissue-specific replication of MuLVs and that different factors may exert a predominant influence at different times during the course of infection.
